Lazzaro C, Bergamaschi R, Zaffaroni M, Totaro R, Paolicelli D
Health Econ Rev. 2025; 15(1):3.
PMID: 39836321
PMC: 11748521.
DOI: 10.1186/s13561-024-00562-y.
Dias J, Tharmanathan P, Arundel C, Welch C, Wu Q, Leighton P
Health Technol Assess. 2024; 28(78):1-262.
PMID: 39644138
PMC: 11647555.
DOI: 10.3310/KGXD8528.
Lazzaro C
J Egypt Public Health Assoc. 2024; 99(1):30.
PMID: 39617863
PMC: 11609134.
DOI: 10.1186/s42506-024-00179-3.
Freitag B, Uncovska M, Meister S, Prinz C, Fehring L
NPJ Digit Med. 2024; 7(1):321.
PMID: 39551808
PMC: 11570631.
DOI: 10.1038/s41746-024-01324-0.
Lal A, Mohebi M, Wyatt K, Ghosh A, Broun K, Gao L
PLoS One. 2024; 19(11):e0313058.
PMID: 39541269
PMC: 11563420.
DOI: 10.1371/journal.pone.0313058.
Development of a Cohort Analytics Tool for Monitoring Progression Patterns in Cardiovascular Diseases: Advanced Stochastic Modeling Approach.
Brahma A, Chatterjee S, Seal K, Fitzpatrick B, Tao Y
JMIR Med Inform. 2024; 12:e59392.
PMID: 39316426
PMC: 11462104.
DOI: 10.2196/59392.
A Hybrid Markov-SPC Approach to Assess Cost Differences in Urgent Care Utilization Using Patient-Reported Data in Inflammatory Bowel Disease.
Oliver B, Melmed G, Siegel C, Kennedy A, Testaverde J, Oberai R
Perm J. 2024; 28(3):234-244.
PMID: 39252533
PMC: 11404662.
DOI: 10.7812/TPP/24.024.
The Health Impacts of Better Access to Axicabtagene Ciloleucel: The Case of Spain.
Cordoba R, Lopez-Corral L, Presa M, Martin-Escudero V, Vadgama S, Casado M
Cancers (Basel). 2024; 16(15).
PMID: 39123439
PMC: 11311991.
DOI: 10.3390/cancers16152712.
The burden of diabetes-associated multiple long-term conditions on years of life spent and lost.
Gregg E, Pratt A, Owens A, Barron E, Dunbar-Rees R, Slade E
Nat Med. 2024; 30(10):2830-2837.
PMID: 39090411
PMC: 11485235.
DOI: 10.1038/s41591-024-03123-2.
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERM.
Wang Y, Fostvedt L, Wojciechowski J, Irby D, Nicholas T
CPT Pharmacometrics Syst Pharmacol. 2024; 13(10):1615-1629.
PMID: 39086047
PMC: 11494912.
DOI: 10.1002/psp4.13207.
Introducing Attribute Association Graphs to Facilitate Medical Data Exploration: Development and Evaluation Using Epidemiological Study Data.
Bellmann L, Wiederhold A, Trube L, Twerenbold R, Uckert F, Gottfried K
JMIR Med Inform. 2024; 12:e49865.
PMID: 39046780
PMC: 11306949.
DOI: 10.2196/49865.
Exposure-response modeling for nausea incidence for cotadutide using a Markov modeling approach.
Yu H, Ueckert S, Zhou L, Cheng J, Robertson D, Hansen L
CPT Pharmacometrics Syst Pharmacol. 2024; 13(9):1582-1594.
PMID: 39044369
PMC: 11533102.
DOI: 10.1002/psp4.13194.
Bystanders Saving Lives with Naloxone: A Scoping Review on Methods to Estimate Overdose Reversals.
Kinoshita A, Saadat S, Chakravarthy B
West J Emerg Med. 2024; 25(4):500-506.
PMID: 39028236
PMC: 11254156.
DOI: 10.5811/westjem.18037.
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Standard of Care in Second-Line Treatment for Relapsed/Refractory Large B-Cell Lymphoma in Spain.
Garcia-Sancho A, Presa M, Pardo C, Martin-Escudero V, Oyaguez I, Ortiz-Maldonado V
Cancers (Basel). 2024; 16(13).
PMID: 39001364
PMC: 11240757.
DOI: 10.3390/cancers16132301.
Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13-15 in the US: projections from an age-structured vaccination model.
Saxena K, Patterson-Lomba O, Gomez-Lievano A, Zion A, Cunningham-Erves J, Kepka D
Front Pediatr. 2024; 12:1393897.
PMID: 38993325
PMC: 11238570.
DOI: 10.3389/fped.2024.1393897.
Can Robotic Arm-assisted Total Knee Arthroplasty Remain Cost-effective in Volume-based Procurement System in China? A Markov Model-based Study.
Zhang Z, Luo Y, Zhang J, Zhang C, Wang X, Chen J
Orthop Surg. 2024; 16(6):1434-1444.
PMID: 38693602
PMC: 11144506.
DOI: 10.1111/os.14078.
Quality-adjusted life years and surgical waiting list: Systematic review of the literature.
de la Plaza Llamas R, Ortega Azor L, Hernandez Yuste M, Gorini L, Latorre-Fragua R, Diaz Candelas D
World J Gastrointest Surg. 2024; 16(4):1155-1164.
PMID: 38690041
PMC: 11056653.
DOI: 10.4240/wjgs.v16.i4.1155.
Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model.
McManus E
Pharmacoecon Open. 2024; 8(4):569-583.
PMID: 38643282
PMC: 11252105.
DOI: 10.1007/s41669-024-00487-6.
Decision-analytic models based on real-world data to assess treatment sequencing in inflammatory bowel disease: A complementary approach to clinical trials.
Benech N, Kirchgesner J
United European Gastroenterol J. 2024; 12(5):535-536.
PMID: 38568741
PMC: 11176904.
DOI: 10.1002/ueg2.12570.
Early prediction of the impact of public health policies on obesity and lifetime risk of type 2 diabetes: A modelling approach.
Bauvin P, Delacote C, Wandji L, Lassailly G, Raverdy V, Pattou F
PLoS One. 2024; 19(3):e0301463.
PMID: 38547299
PMC: 10977742.
DOI: 10.1371/journal.pone.0301463.